-
1
-
-
0027476816
-
Flosequinan
-
Barnett DB (1993) Flosequinan. Lancet 341:733-736
-
(1993)
Lancet
, vol.341
, pp. 733-736
-
-
Barnett, D.B.1
-
2
-
-
8944244757
-
The pharmacokinetic profile of flosequinan 100 mg on severely impaired hepatic patients
-
Callejas HJ, Gallo BV, O'Connor PC, Weidler DJ (1990) The pharmacokinetic profile of flosequinan 100 mg on severely impaired hepatic patients. J Clin Pharmacol 30:92
-
(1990)
J Clin Pharmacol
, vol.30
, pp. 92
-
-
Callejas, H.J.1
Gallo, B.V.2
O'Connor, P.C.3
Weidler, D.J.4
-
3
-
-
0023941543
-
Flosequinan in heart failure: Acute haemodynamic and longer term symptomatic effects
-
Cowley AJ, Wynne RD, Stainer K, Fullwood L, Rowley JM, Hampton JR (1988) Flosequinan in heart failure: acute haemodynamic and longer term symptomatic effects. Br Med J 297:169-172
-
(1988)
Br Med J
, vol.297
, pp. 169-172
-
-
Cowley, A.J.1
Wynne, R.D.2
Stainer, K.3
Fullwood, L.4
Rowley, J.M.5
Hampton, J.R.6
-
4
-
-
0024573350
-
Effect of flosequinan on exercise capacity and symptoms in severe heart failure
-
Elborn JS, Stanford CF, Nicholls DP (1989) Effect of flosequinan on exercise capacity and symptoms in severe heart failure. Br Heart J 61:331-335
-
(1989)
Br Heart J
, vol.61
, pp. 331-335
-
-
Elborn, J.S.1
Stanford, C.F.2
Nicholls, D.P.3
-
5
-
-
0017826090
-
Reduced drug elimination in congestive heart failure: Studies using aminopyrine as a model drug
-
Hepner GN, Vesell ES, Tantum KR (1978) Reduced drug elimination in congestive heart failure: studies using aminopyrine as a model drug. Am J Med 65:271-276
-
(1978)
Am J Med
, vol.65
, pp. 271-276
-
-
Hepner, G.N.1
Vesell, E.S.2
Tantum, K.R.3
-
6
-
-
0026780168
-
The effects of flosequinan on endothelin-1-induced changes in inositol 1,4,5-triphosphate levels and protein kinase C activity in rat aorta
-
Lang D, Lewis MJ (1992) The effects of flosequinan on endothelin-1-induced changes in inositol 1,4,5-triphosphate levels and protein kinase C activity in rat aorta. Eur J Pharmacol 226:259-264
-
(1992)
Eur J Pharmacol
, vol.226
, pp. 259-264
-
-
Lang, D.1
Lewis, M.J.2
-
7
-
-
0025848862
-
Flosequinan, a vasodilator with a novel mechanism of action
-
Resnick MS, Maitland LA, Morgan KG (1991) Flosequinan, a vasodilator with a novel mechanism of action. Br J Pharmacol 102:974-978
-
(1991)
Br J Pharmacol
, vol.102
, pp. 974-978
-
-
Resnick, M.S.1
Maitland, L.A.2
Morgan, K.G.3
-
8
-
-
0026022693
-
The effects of flosequinan on regional blood flow in normal man
-
Scott RA, Woods KL, Barnett DB (1991) The effects of flosequinan on regional blood flow in normal man. Br J Clin Pharmacol 31:41-46
-
(1991)
Br J Clin Pharmacol
, vol.31
, pp. 41-46
-
-
Scott, R.A.1
Woods, K.L.2
Barnett, D.B.3
-
9
-
-
0023765108
-
Clinical pharmacokinetics in heart failure. An updated review
-
Shammas FV, Dickstein K (1988) Clinical pharmacokinetics in heart failure. An updated review. Clin Pharmacokin 15:94-113
-
(1988)
Clin Pharmacokin
, vol.15
, pp. 94-113
-
-
Shammas, F.V.1
Dickstein, K.2
-
10
-
-
0026669244
-
A double-blind, parallel-group comparison of flosequinan and enalapril in the treatment of chronic heart failure
-
Silke B, Tennet H, Fischer-Hansen J, Keller N, Heikkila J, Salminen K (1992) A double-blind, parallel-group comparison of flosequinan and enalapril in the treatment of chronic heart failure. Eur Heart J 13:1092-1100
-
(1992)
Eur Heart J
, vol.13
, pp. 1092-1100
-
-
Silke, B.1
Tennet, H.2
Fischer-Hansen, J.3
Keller, N.4
Heikkila, J.5
Salminen, K.6
-
11
-
-
0015610111
-
Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans
-
Thomson PD, Melmon KL, Richardson JA et al (1973) Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans. Ann Intern Med 78:499-508
-
(1973)
Ann Intern Med
, vol.78
, pp. 499-508
-
-
Thomson, P.D.1
Melmon, K.L.2
Richardson, J.A.3
-
12
-
-
0021930231
-
The pharmacokinetics and haemodynamics of BTS 49465 and its major metabolite in healthy volunteers
-
Wynne RD, Crampton EL, Hind ID (1985) The pharmacokinetics and haemodynamics of BTS 49465 and its major metabolite in healthy volunteers. Eur J Clin Pharmacol 28:659-664
-
(1985)
Eur J Clin Pharmacol
, vol.28
, pp. 659-664
-
-
Wynne, R.D.1
Crampton, E.L.2
Hind, I.D.3
|